chr1-245927945-C-T
Variant summary
Our verdict is Likely benign. Variant got -2 ACMG points: 2P and 4B. PM2BP4_Strong
The NM_001167740.2(SMYD3):c.688G>A(p.Glu230Lys) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.000254 in 1,611,540 control chromosomes in the GnomAD database, with no homozygous occurrence. In-silico tool predicts a benign outcome for this variant. 15/21 in silico tools predict a benign outcome for this variant. Variant has been reported in ClinVar as Uncertain significance (★).
Frequency
Consequence
NM_001167740.2 missense
Scores
Clinical Significance
Conservation
Genome browser will be placed here
ACMG classification
Verdict is Likely_benign. Variant got -2 ACMG points.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | UniProt |
---|---|---|---|---|---|---|---|
SMYD3 | NM_001167740.2 | c.688G>A | p.Glu230Lys | missense_variant | 7/12 | ENST00000490107.6 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|
SMYD3 | ENST00000490107.6 | c.688G>A | p.Glu230Lys | missense_variant | 7/12 | 1 | NM_001167740.2 | P1 |
Frequencies
GnomAD3 genomes AF: 0.000145 AC: 22AN: 151978Hom.: 0 Cov.: 31
GnomAD3 exomes AF: 0.000140 AC: 35AN: 250450Hom.: 0 AF XY: 0.000126 AC XY: 17AN XY: 135442
GnomAD4 exome AF: 0.000265 AC: 387AN: 1459444Hom.: 0 Cov.: 31 AF XY: 0.000264 AC XY: 192AN XY: 726006
GnomAD4 genome AF: 0.000145 AC: 22AN: 152096Hom.: 0 Cov.: 31 AF XY: 0.000121 AC XY: 9AN XY: 74338
ClinVar
Submissions by phenotype
not specified Uncertain:1
Uncertain significance, criteria provided, single submitter | clinical testing | Ambry Genetics | Aug 12, 2021 | The c.688G>A (p.E230K) alteration is located in exon 7 (coding exon 7) of the SMYD3 gene. This alteration results from a G to A substitution at nucleotide position 688, causing the glutamic acid (E) at amino acid position 230 to be replaced by a lysine (K). Based on insufficient or conflicting evidence, the clinical significance of this alteration remains unclear. - |
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at